BIOFORCE NANOSCIENCES HOLDINGS, INC. Increase (Decrease) in Accounts Receivable
BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH) reported Increase (Decrease) in Accounts Receivable of -$5.74 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2021-02-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2021-02-16
- BIOFORCE NANOSCIENCES HOLDINGS, INC. increase (decrease) in accounts receivable for the quarter ending 2019-12-31 was -$5.96K, a 2773.54% decline year-over-year.
- BIOFORCE NANOSCIENCES HOLDINGS, INC. increase (decrease) in accounts receivable for the quarter ending 2019-09-30 was $0.00, a 100.00% decline year-over-year.
- BIOFORCE NANOSCIENCES HOLDINGS, INC. increase (decrease) in accounts receivable for the quarter ending 2019-06-30 was $112.00.
- BIOFORCE NANOSCIENCES HOLDINGS, INC. increase (decrease) in accounts receivable for the quarter ending 2019-03-31 was $115.00.
- BIOFORCE NANOSCIENCES HOLDINGS, INC. increase (decrease) in accounts receivable for fiscal 2019 was -$5.74K, a 564.37% decline from fiscal 2018.
- BIOFORCE NANOSCIENCES HOLDINGS, INC. increase (decrease) in accounts receivable for fiscal 2018 was $1.24K, a 72.56% decline from fiscal 2017.
- BIOFORCE NANOSCIENCES HOLDINGS, INC. increase (decrease) in accounts receivable for fiscal 2017 was $4.50K.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2019-12-31 | -$5.96K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | -$5.96K derived: sum of 2 quarters · filed 2021-02-16 | -$5.85K derived: sum of 3 quarters · filed 2021-02-16 | -$5.74K 10-K · filed 2021-02-16 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-23 | $112.00 derived: sum of 2 quarters · filed 2020-10-23 | $227.00 10-Q · filed 2020-10-23 | $450.00 derived: sum of 4 quarters · filed 2020-10-23 |
| 2019-06-30 | $112.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-22 | $227.00 10-Q · filed 2020-07-22 | $450.00 derived: sum of 3 quarters · filed 2020-07-22 | $5.96K derived: sum of 4 quarters · filed 2020-07-22 |
| 2019-03-31 | $115.00 10-Q · filed 2020-05-04 | $338.00 derived: sum of 2 quarters · filed 2020-05-04 | $5.85K derived: sum of 3 quarters · filed 2020-05-04 | $5.85K derived: sum of 4 quarters · filed 2020-05-04 |
| 2018-12-31 | $223.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-03-09 | $5.74K derived: sum of 2 quarters · filed 2020-03-09 | $5.74K derived: sum of 3 quarters · filed 2020-03-09 | $1.24K 10-K/A · filed 2020-03-09 |
| 2018-09-30 | $5.51K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $5.51K derived: sum of 2 quarters · filed 2019-11-05 | $1.01K 10-Q · filed 2019-11-05 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-22 | -$4.50K 10-Q · filed 2019-07-22 | ||
| 2018-03-31 | -$4.50K 10-Q · filed 2019-04-30 | |||
| 2017-12-31 | $4.50K 10-K · filed 2019-03-29 |